CClinicalTrials.gg
CompletedNCT04512391Updated Mar 11, 2021

Analgesic Efficacy of Erector Spinae Plane Block After Breast Cancer Surgery

An observational study in Postoperative Pain and Breast Cancer, sponsored by TC Erciyes University. Completed at 1 site in Turkey. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2021-03-11.

Sponsored by TC Erciyes University · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
40
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

Erector spinae plane block(ESPB), which is firstly used for thoracic neuropathic pain, is newly developed and highly promising fascial plane block for providing postoperative analgesia for a great deal of surgeries including breast surgery. The investigators aim to study efficacy of ESPB for patients who undergone breast cancer surgery and is expected to benefit from opioid-sparing effect of this technique.

Read the detailed description

This is a retrospective, single-center clinical trial to evaluate analgesic efficacy of Erector spinae plane block (ESPB) after breast cancer surgery. Participant's demographics and medical history, type and extent of surgery, systemic opioid and non-opioid analgesic consumptions, hemodynamic variables and adverse events during and first 24 hours after surgery. After operation, pain scores at first 24 hours, 1., 3., and 6. month will be obtanied from surgical ward and pain clinic registires. patient controlled analgesia device usage history will be obtained from device database at our clinic.

02

Conditions studied

  • Postoperative Pain
  • Breast Cancer

Keywords

  • Erector spinae plane block
  • breast cancer
  • surgery
  • postoperative pain
  • analgesic
03

In context

Breast Neoplasms

12,543 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 40 is below the median of 184 across 2,642 observational studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

TC Erciyes University is the lead sponsor of 341 studies on the registry; 76 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Sampling method
Probability sample

Study population

all patients undergoing breast surgery for breast cancer between September 2018 and December 2019 were included in our study.

Inclusion criteria

  • ASA I-II patients undergoing breast surgery for breast cancer
  • Becoming available of complete records about study data

Exclusion criteria

Exclusion Criteria:

  • ASA III-IV patients
  • missing records about study data
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
40 participants (actual)
Patient registry
No

Groups and cohorts

  • Erector Spinae

    patients who are administered ultrasound guided ESPB at T4 vertebrae level with long acting local anesthetic (%0,25 bupivacaine) and followed up with patient controlled analgesia device and all records about aforementioned data is completely available.

    Procedure: Ultrasound guided Erector Spinae Plane Block (ESPB)

  • Control

    patients who are not administered any regional analgesic technique and followed up with patient controlled analgesia device and all records about aforementioned data is completely available.

Interventions

  • ProcedureUltrasound guided Erector Spinae Plane Block (ESPB)

    Ultrasound guided ESPB is applied at T4 vertebrae level, 3 cm lateral to mid-line where transverse process lies. After identification of transverse process, needle is advanced in plane and real time visualisation on ultrasound screen. When bonny contact is encountered, normal saline is injected for verification of placement, then, 25 ml %0,25 bupivacaine is injected plane between transverse process and erector spinae muscles.

06

What researchers measure

Primary outcomes

  1. Opioid Consumption

    all patients were given 0.05 mg/kg morphine iv and 1 gr paracetamol 30 minutes before end of surgery and in the recovery room, a patient- controlled analgesia device containing morphine 0.5 mg/ml, set to deliver a 1mg bolus dose of morphine with an 10 min lockout time. Total morphine consumption during the 24 hours postoperative period will recorded at 5 times intervals ( 2, 4, 6, 12, 24 hours).

    Time frame: First 24 hours after surgery

  2. Verbal Analog Pain Scores on rest and movement

    A Research assistant, blinded to the group allocation, interviewed patients and collected data at 5 times intervals ( 2, 4, 6, 12, 24, hours) in the 24 hours postoperatively. Patients were asked to rate their pain using verbal analog scale, where 0= no pain and 10= worst pain possible.

    Time frame: First 24 hours after surgery, at 1., 3., 6. month

Secondary outcomes

  1. Demographic Data

    Age, sex, medical history, BMI, ASA (American Society of Anesthesiologists) status, Duration and type of surgery were recorded

    Time frame: First 24 hours after surgery

  2. Blood Pressures

    systolic, diastolic and mean arterial blood pressures as mmHg

    Time frame: during and first 24 hours after surgery

  3. Heart Rate

    Heart rate as beat per minute (BPM)

    Time frame: during and first 24 hours after surgery

  4. incidence of adverse effects (like nausea and vomiting)

    incidence of nausea and vomiting during the 24 hours postoperative period was recorded recorded at 5 times intervals ( 2, 4, 6, 12, 24 hours)

    Time frame: First 24 hours after surgery

  5. Rescue analgesic requirement

    number of request and dosages of non opioid analgesics used for VAS equal or greater than 5 or patient request.

    Time frame: First 24 hours after surgery

07

Study locations

1 site
  • TC erciyes university
    Kayseri, Melikgazi, Turkey
08

References and documents

Publications

  • Forero M, Adhikary SD, Lopez H, Tsui C, Chin KJ. The Erector Spinae Plane Block: A Novel Analgesic Technique in Thoracic Neuropathic Pain. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):621-7. doi: 10.1097/AAP.0000000000000451. PubMed 27501016 ↗
  • Gurkan Y, Aksu C, Kus A, Yorukoglu UH, Kilic CT. Ultrasound guided erector spinae plane block reduces postoperative opioid consumption following breast surgery: A randomized controlled study. J Clin Anesth. 2018 Nov;50:65-68. doi: 10.1016/j.jclinane.2018.06.033. Epub 2018 Jul 2. PubMed 29980005 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 11, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04512391
Lead sponsor
TC Erciyes University
Responsible party
ersin sönmez (Research Assistant, TC Erciyes University) — Principal investigator
First posted
Aug 13, 2020
Start date
Sep 1, 2018
Primary completion
Dec 31, 2019
Completion
Mar 3, 2021
Last update
Mar 11, 2021

Study contacts

ersin SÖNMEZ
principal investigator · Research Asisstant

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion